Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | GABRP | O00591 | 2/20 | 0.39 |
| ▸ | GABRD | O14764 | 2/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.39 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6265118 | 1.00 | GABRR1 (0.42) | GABRR1TSHRGABRR2BLMGABRR3 | |
| SCHEMBL4585237 | 0.85 | GABRR1 (0.46) | GABRR1BLMCYP1A2TP53 | |
| SCHEMBL4585236 | 0.85 | GABRR1 (0.46) | GABRR1BLMCYP1A2TP53 | |
| SCHEMBL12973059 | 0.80 | — | — | |
| SCHEMBL15352 | 0.80 | — | — | |
| SCHEMBL15353 | 0.80 | — | — | |
| SCHEMBL265515 | 0.78 | — | — | |
| SCHEMBL277662 | 0.78 | — | — | |
| SCHEMBL11465249 | 0.78 | — | — | |
| SCHEMBL5314429 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12180413-B2 | Solid coolant concentrates and production thereof | BASF SE (DE) | 2024-12-31 | — | — | US | claimed |
| US-20240409801-A1 | SOLID COOLANT CONCENTRATES AND PRODUCTION THEREOF | BASF SE (DE) | 2024-12-12 | — | — | US | claimed |
| US-20240110088-A1 | COOLANTS WITH IMPROVED TEMPERATURE STABILITY | BASF SE (DE) | 2024-04-04 | — | — | US | claimed |
| US-20240052228-A1 | SOLID COOLANT CONCENTRATES AND PRODUCTION THEREOF | BASE SE (DE) | 2024-02-15 | — | — | US | claimed |
| US-12534678-B2 | Aqueous emulsifier package with anionic surfactant for fuel emulsion | BASF SE (DE) | 2026-01-27 | — | — | US | disclosed |
| EP-4124640-B1 | NOVEL USE FOR COOLANTS WITH LOW ELECTRICAL CONDUCTIVITY | BASF SE (DE) | 2026-01-21 | — | — | EP | disclosed |
| EP-4556456-A1 | PROCESS FOR MAKING ETHYLENE GLYCOLS AND ETHOXYLATES BASED ON NON-FOSSIL ENERGY | BASF SE (DE) | 2025-05-21 | — | — | EP | disclosed |
| US-20240409801-A1 | SOLID COOLANT CONCENTRATES AND PRODUCTION THEREOF | BASF SE (DE) | 2024-12-12 | — | — | US | disclosed |
| EP-4464757-A1 | NOVEL COOLANT WITH LOW ELECTRICAL CONDUCTIVITY | BASF SE (DE) | 2024-11-20 | — | — | EP | disclosed |
| US-20240352300-A1 | NOVEL COOLANT WITH LOW ELECTRICAL CONDUCTIVITY | BASF SE (DE) | 2024-10-24 | — | — | US | disclosed |
| US-20240343962-A1 | NOVEL USE FOR COOLANTS WITH LOW ELECTRICAL CONDUCTIVITY | BASF SE (DE) | 2024-10-17 | — | — | US | disclosed |
| US-20240309257-A1 | NOVEL COOLANT WITH LOW ELECTRICAL CONDUCTIVITY | BASF SE (DE) | 2024-09-19 | — | — | US | disclosed |
| EP-0388236-B1 | Fuel oil compositions | EXXON CHEMICAL PATENTS INC (US) | 1993-11-24 | — | — | EP | disclosed |
| WO-1993008244-A1 | FUEL OIL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1993-04-29 | — | — | WO | disclosed |
| EP-0525052-A1 | FUEL OIL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1993-02-03 | — | — | EP | disclosed |
| US-5152807-A | Discoloration inhibition | EXXON CHEMICAL PATENTS INC. (US) | 1992-10-06 | — | — | US | disclosed |
| WO-1991016408-A1 | FUEL OIL COMPOSITIONS | EXXON CHEMICAL LIMITED (GB) | 1991-10-31 | — | — | WO | disclosed |
| EP-0391735-A1 | Fuel oil compositions | EXXON CHEMICAL PATENTS INC. (US) | 1990-10-10 | — | — | EP | disclosed |
| EP-0388236-A1 | Fuel oil compositions | EXXON CHEMICAL PATENTS INC. (US) | 1990-09-19 | — | — | EP | disclosed |
| EP-0385778-A1 | Fuel oil compositions | EXXON CHEMICAL PATENTS INC. (US) | 1990-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534678-B2 | Aqueous emulsifier package with anionic surfactant for fuel emulsion | CS, SCO2, ELOVL1 | GABRR1 2591/4885TSHR 999/4885GABRR2 2546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.